EU-COVAT-1 AGED – VACCELERATE

A Multinational, Phase 2, Randomised, Adaptive Protocol to Evaluate Immunogenicity and Reactogenicity of Different COVID-19 Vaccines Administration in Older Adults (≥75) Already Vaccinated Against SARS-CoV-2

Lead: Oliver Cornely, Institution/Sponsor: UHC, Germany

Details:

A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network – PubMed (nih.gov)

https://portal.uni-koeln.de/en/universitaet/aktuell/press-releases/single-news/studie-zur-wirksamkeit-der-boosterimpfung-gegen-corona-startet

https://clinicaltrials.gov/ct2/show/NCT05160766?cond=Covat+aged&draw=2&rank=1

Publications:

Protocol: https://pubmed.ncbi.nlm.nih.gov/36209129/

Results Part A: https://pubmed.ncbi.nlm.nih.gov/37919141/

Results Part B: https://pubmed.ncbi.nlm.nih.gov/38992789/

Videos:

Part A (English): https://www.youtube.com/watch?v=STc6VxETqZ8

Part A (German): https://www.youtube.com/watch?v=TGXIsFITMD0

Part B (English): https://youtu.be/24E74mUP6o8

Part B (English, laypersons): https://youtu.be/d50v-qDwZm8

Part B (German, laypersons): https://youtu.be/ghwxuTx8MyU

Part B (Spanish): https://youtu.be/3j4emBdTdvo